A Colecchia

Summary

Affiliation: University of Bologna
Country: Italy

Publications

  1. ncbi Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study
    A Colecchia
    Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
    Minerva Gastroenterol Dietol 52:349-58. 2006
  2. ncbi Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation
    F Lodato
    Department of Digestive Diseases and Internal Medicine, Azienda Ospedaliero Universitaria Policlinico Sant Orsola Malpighi, Bologna, Italy
    Aliment Pharmacol Ther 28:450-7. 2008
  3. ncbi Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels
    D Festi
    Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
    World J Gastroenterol 11:142-8. 2005
  4. ncbi Safety of interferon beta treatment for chronic HCV hepatitis
    D Festi
    Dipartment of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
    World J Gastroenterol 10:12-6. 2004
  5. ncbi Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid
    F Azzaroli
    Dipartimento di Medicina Interna e Gastroenterologia, Universita degli Studi di Bologna, Bologna, Italy
    Aliment Pharmacol Ther 26:1139-46. 2007
  6. ncbi A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis
    F Azzaroli
    Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
    Aliment Pharmacol Ther 24:129-36. 2006
  7. ncbi Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation
    Fabio Piscaglia
    Division of Internal Medicine, Department of Digestive Disease and Internal Medicine, St Orsola Malpighi University Hospital, Bologna, Italy
    Liver Transpl 16:658-67. 2010
  8. ncbi Transjugular intrahepatic portosystemic shunt: a case report of rescue management of unrestrainable variceal bleeding in a pregnant woman
    F Lodato
    Department of Digestive Diseases and Internal Medicine, S Orsola Malpighi Hospital, University of Bologna, Italy
    Dig Liver Dis 40:387-90. 2008
  9. ncbi Breath tests with stable isotopes: have they a role in liver transplantation?
    D Festi
    Department of Internal Medicine and Gastroenterology, University G. D'Annunzio, Chieti, Italy
    Eur Rev Med Pharmacol Sci 8:55-8. 2004
  10. ncbi Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers
    G Mazzella
    Dipartimento di Malattie dell Apparato Digerente, del Metabolismo and delle Malattie Infettive, Azienda Ospedaliera di Bologna, Universita di Bologna, Italy
    Hepatology 33:504-8. 2001

Collaborators

Detail Information

Publications15

  1. ncbi Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study
    A Colecchia
    Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
    Minerva Gastroenterol Dietol 52:349-58. 2006
    ..The aim of this study was to evaluate the efficacy and safety of this symbiotic in patients with constipation-variant IBS...
  2. ncbi Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation
    F Lodato
    Department of Digestive Diseases and Internal Medicine, Azienda Ospedaliero Universitaria Policlinico Sant Orsola Malpighi, Bologna, Italy
    Aliment Pharmacol Ther 28:450-7. 2008
    ..Treatment of hepatitis C virus (HCV) recurrence after liver transplantation (LT) is difficult with low response rates...
  3. ncbi Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels
    D Festi
    Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
    World J Gastroenterol 11:142-8. 2005
    ....
  4. ncbi Safety of interferon beta treatment for chronic HCV hepatitis
    D Festi
    Dipartment of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
    World J Gastroenterol 10:12-6. 2004
    ..If further studies will confirm the efficacy of combined IFNbeta and ribavirin treatment, this regimen could represent a safe and alternative therapeutic option in selected patients...
  5. ncbi Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid
    F Azzaroli
    Dipartimento di Medicina Interna e Gastroenterologia, Universita degli Studi di Bologna, Bologna, Italy
    Aliment Pharmacol Ther 26:1139-46. 2007
    ..The effects of ursodeoxycholic acid on human placental bile acids and bilirubin transporters in intrahepatic cholestasis of pregnancy are still undefined...
  6. ncbi A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis
    F Azzaroli
    Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
    Aliment Pharmacol Ther 24:129-36. 2006
    ..Incidence of hepatocellular carcinoma in hepatitis C virus-related cirrhosis is 4% per year. Although cost-effective, current screening could be improved...
  7. ncbi Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation
    Fabio Piscaglia
    Division of Internal Medicine, Department of Digestive Disease and Internal Medicine, St Orsola Malpighi University Hospital, Bologna, Italy
    Liver Transpl 16:658-67. 2010
    ..In conclusion, for a patient with HCC and portal vein thrombosis, appropriate investigations can establish whether the thrombosis is benign; patients with HCC and benign portal vein thrombosis are candidates for liver transplantation...
  8. ncbi Transjugular intrahepatic portosystemic shunt: a case report of rescue management of unrestrainable variceal bleeding in a pregnant woman
    F Lodato
    Department of Digestive Diseases and Internal Medicine, S Orsola Malpighi Hospital, University of Bologna, Italy
    Dig Liver Dis 40:387-90. 2008
    ..Transjugular intrahepatic portosystemic shunt may represent a rescue treatment for failed attempts of band ligation or sclerotherapy...
  9. ncbi Breath tests with stable isotopes: have they a role in liver transplantation?
    D Festi
    Department of Internal Medicine and Gastroenterology, University G. D'Annunzio, Chieti, Italy
    Eur Rev Med Pharmacol Sci 8:55-8. 2004
    ..The usefulness of breath tests has been documented in liver disease patients both before and after liver transplantation, in the early as well as in the late phase...
  10. ncbi Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers
    G Mazzella
    Dipartimento di Malattie dell Apparato Digerente, del Metabolismo and delle Malattie Infettive, Azienda Ospedaliera di Bologna, Universita di Bologna, Italy
    Hepatology 33:504-8. 2001
    ..8 +/- 2.4 and 0.9 +/- 0.14 micromol/L, respectively. We conclude that increasing the dose of UDCA more effectively controls ICP and improves maternal clinical outcome after delivery...
  11. ncbi Hepatic steatosis in obese patients: clinical aspects and prognostic significance
    D Festi
    Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
    Obes Rev 5:27-42. 2004
    ..Modifications in lifestyle (e.g. diet and exercise) to reduce obesity remain the mainstay of prevention and treatment of a disease, which puts a large number of individuals at risk of advanced liver disease in the near future...
  12. ncbi Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosis
    E Roda
    Department of Internal Medicine and Gastroenterology, University of Bologna, S. Drsola-Malpighi Hospital, Italy
    Dig Liver Dis 34:523-7. 2002
    ..CONCLUSIONS: In early primary biliary cirrhosis, higher dose ursodeoxycholic acid appears to be more effective than doses currently recommended...
  13. ncbi Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study
    F Lodato
    Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
    J Viral Hepat 12:536-42. 2005
    ....
  14. ncbi Gallbladder motility and functional gastrointestinal disorders
    A Colecchia
    Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
    Dig Liver Dis 35:S30-4. 2003
    ....
  15. ncbi Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients
    A Colecchia
    Dipartmento di Medicina Interna e Gastroenterologia Policlinico S.Orsola-Malpighi Via Massarenti 9, Bologna 40138, Italy
    World J Gastroenterol 12:5336-43. 2006
    ..These results confirm the pathogenetic role of gastrointestinal motility in gallstone disease and suggest an additional mechanism of action for UDCA in reducing bile cholesterol supersaturation...